CDMOs & Manufacturing – Page 6 – Discover Pharma

Welcome to Discover Pharma! Today is : May 2, 2026

CDMOs & Manufacturing

Biomanufacturing,CDMOs & Manufacturing,Partnerships & Funding,Technology and platforms
Lonza to acquire Redberry to expand rapid microbiology testing for pharmaceutical quality control
Lonza has signed an agreement to acquire Redberry, a French [...]

November 6, 2025
Artificial Intelligence,Biologics & Biosimilars,CDMOs & Manufacturing,Clinical studies,Market Access & Commercialization
KBI Biopharma CBO Katie Edgar on ADCs, biologics, and digital innovation in drug development
Discover Pharma caught up with Katie Edgar, chief business officer [...]

November 13, 2025
Artificial Intelligence,CDMOs & Manufacturing,Data Management,Peptides,Research & Development
Solvias CSO Danny Galbraith on peptides, ADCs and AI driving drug development innovation
Discover Pharma caught up with Danny Galbraith, chief scientific officer [...]

November 7, 2025
Artificial Intelligence,Biotech,CDMOs & Manufacturing
Pharma leaders on AI, automation, and ESG: How CDMOs are reshaping development at CPHI Frankfurt 2025
At another of this year’s CPHI Frankfurt 2025 roundtable, executives [...]

November 6, 2025
Biologics & Biosimilars,Biomanufacturing,Biotech,CDMOs & Manufacturing,Clinical Development,Events and Conferences,Partnerships & Funding,Pharmaceuticals and therapeutics
Personal connections at CPhI Frankfurt 2025: How trust drives long-term pharma relationships
A roundtable at CPhI Frankfurt 2025 with industry leaders from [...]

November 5, 2025
Biomanufacturing,CDMOs & Manufacturing,Cell & Gene Therapy,Pharmaceuticals and therapeutics
NurExone joins ARMI BioFab Startup Lab to boost US regenerative manufacturing
NurExone Biologic Inc has been accepted into the BioFab Startup [...]

November 5, 2025
Biologics & Biosimilars,Biomanufacturing,CDMOs & Manufacturing,Movers & Shakers,Pharmaceuticals and therapeutics,Supply Chain & Logistics
CDMO Argonaut appoints Rick Hancock to drive next phase of biologics and commercial manufacturing
Argonaut Manufacturing Services has named Rick Hancock as chief executive [...]

November 5, 2025
Biologics & Biosimilars,CDMOs & Manufacturing,Cell & Gene Therapy
Thermo Fisher Scientific accelerates biologic therapeutics development with new CHO K-1 cell line
October 16, 2025
Biologics & Biosimilars,Biomanufacturing,CDMOs & Manufacturing,Drug Development,Pharmaceuticals and therapeutics,Supply Chain & Logistics
Axplora announces over €100 million global investments to expand pharmaceutical manufacturing capabilities
Axplora has initiated global investments exceeding €100 million in 2025 [...]

October 8, 2025
Biomanufacturing,Biotech,CDMOs & Manufacturing,Cell & Gene Therapy,Pharmaceuticals and therapeutics
BBG Advanced Therapies and CELLforCURE partner to provide transatlantic ATMP manufacturing solutions
BBG Advanced Therapies (BBGAT), a subsidiary of BioBridge Global and [...]

October 7, 2025